LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all patients with CLL have to have therapy. Despite all modern advancements, the iwCLL still recommends watchful observation for individuals with asymptomatic illness.86 This advice is based on a minimum of two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,